SCHEMBL20421656

SCHEMBL20421656

CCN(CC)c1cccc(C)c1-c1c(C)cccc1NC(C)=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.50
▸ HPGD P15428 2/20 0.50
▸ PARP14 Q460N5 1/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.44
▸ HSD17B10 Q99714 2/20 0.43
▸ MAOA P21397 1/20 0.42
▸ TSHR P16473 3/20 0.42
▸ LMNA P02545 3/20 0.42
▸ GAA P10253 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ MAPK1 P28482 3/20 0.41
▸ CASP3 P42574 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ MAPT P10636 2/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ MC4R P32245 1/20 0.39
▸ SCN4A P35499 1/20 0.39
▸ MC3R P41968 1/20 0.39
▸ HTR3A P46098 1/20 0.39
▸ SCN5A Q14524 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20421627 0.84 ALDH1A1 (0.54) ALDH1A1HPGDPARP14HSD17B10MAOA
SCHEMBL20436302 0.81 SMN1; SMN2 (0.49) ALDH1A1HPGDTSHRLMNAGAA
SCHEMBL10805152 0.80 HSD17B10 (0.54) ALDH1A1HPGDNPSR1HSD17B10MAOA
SCHEMBL20436310 0.78 NLRP3 (0.36) ALDH1A1HPGDNPSR1HSD17B10LMNA
SCHEMBL20436303 0.76 MGLL (0.46) ALDH1A1HPGDNPSR1GAAKMT2A
SCHEMBL9350593 0.75 HSD17B10 (0.47) ALDH1A1HPGDNPSR1HSD17B10TSHR
SCHEMBL20421679 0.75 ALDH1A1 (0.59) ALDH1A1HPGDPARP14HSD17B10MAOA
SCHEMBL20436308 0.74 ITGB3 (0.64) ALDH1A1NPSR1TSHRGAAMAPK1
SCHEMBL20436328 0.73 ACE (0.37) ALDH1A1HPGDHSD17B10LMNAGAA
SCHEMBL20421624 0.72 CD44 (0.42) ALDH1A1HPGDHSD17B10TSHRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11327060-B2 Method for analyzing enantiomer AJINOMOTO CO., INC. (JP) 2022-05-10 — — US disclosed
US-11327060-B2 Method for analyzing enantiomer AJINOMOTO CO., INC. (JP) 2022-05-10 — — US disclosed
EP-3358346-B1 ENANTIOMER ANALYSIS METHOD AJINOMOTO KK (JP) 2022-01-19 — — EP disclosed
EP-3358346-B1 ENANTIOMER ANALYSIS METHOD AJINOMOTO KK (JP) 2022-01-19 — — EP disclosed
EP-3358346-A1 ENANTIOMER ANALYSIS METHOD Ajinomoto Co., Inc. (JP) 2018-08-08 — — EP disclosed
EP-3358346-A1 ENANTIOMER ANALYSIS METHOD Ajinomoto Co., Inc. (JP) 2018-08-08 — — EP disclosed
US-20180217113-A1 METHOD FOR ANALYZING ENANTIOMER AJINOMOTO CO., INC. (JP) 2018-08-02 — — US disclosed
US-20180217113-A1 METHOD FOR ANALYZING ENANTIOMER AJINOMOTO CO., INC. (JP) 2018-08-02 — — US disclosed
US-20180217113-A1 METHOD FOR ANALYZING ENANTIOMER AJINOMOTO CO., INC. (JP) 2018-08-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11327060-B2 Method for analyzing enantiomer DCX, INF2, SRD5A2 ALDH1A1 834/4885HPGD 1872/4885PARP14 2177/4885
US-20180217113-A1 METHOD FOR ANALYZING ENANTIOMER DCX, INF2, SRD5A2 ALDH1A1 834/4885HPGD 1872/4885PARP14 2177/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback